Ravi Amaravadi, Md

This study tests whether adding hydroxychloroquine (a malaria drug) to standard immunotherapy (nivolumab with or without ipilimumab) can improve treatment for advanced melanoma. About 94 adults with stage III or IV melanoma will participate. The goal is to find the safest dose an…